Association of midlife blood pressure to late-life cognitive decline and brain morphology

Gary E. Swan, Charles DeCarli, B. L. Miller, T. Reed, P. A. Wolf, L. M. Jack, D. Carmelli

Research output: Contribution to journalArticle

274 Citations (Scopus)

Abstract

Objective: To investigate the association between midlife systolic blood pressure (SBP) and late-life cognitive decline and brain morphology in a sample of community-dwelling elderly men 68 to 79 years of age. Methods: Subjects are surviving members from the prospective National Heart, Lung, and Blood Institute Twin Study (intake, 1969 to 1972)who, when examined for a fourth time in 1995 through 1997, underwent brain MRI and repeated assessment of neurobehavioral functioning. Quantification of the MR images determined cerebral volume and total volume of white matter hyperintensities (WMHIs) for 392 subjects. Midlife SBP levels measured in 1970, 1980, and 1985 were used to classify subjects into low, medium, and high midlife SBP categories. A 10- year change in performance on the Mini-Mental State Examination, Digit Symbol Substitution Test, Benton Visual Retention Test, and Verbal Fluency Test was also calculated for these subjects. For all reported analyses, patients were treated as genetically unrelated individuals. Results: Subjects with high midlife SBP experienced a greater decline in cognitive performance and had larger WMHI volumes at follow-up in late life than did those with low midlife SBP. Decreased brain parenchyma and increased WMHI volumes were associated with decline in neurobehavioral functioning as measured in late life independent of age, education, and baseline levels of cognition. Conclusions: Midlife SBP is a significant predictor of both decline in cognitive function and MR volumetric measures of brain atrophy in late life. Because decline in neurobehavioral functioning was associated with decreased brain volume and increased WMHI volume, we conclude that the long-term impact of elevated SBP on decline in late-life neurobehavioral functioning is likely to be mediated through its chronic, negative effect on structural characteristics of the brain.

Original languageEnglish (US)
Pages (from-to)986-993
Number of pages8
JournalNeurology
Volume51
Issue number4
StatePublished - Oct 1998
Externally publishedYes

Fingerprint

Blood Pressure
Brain
Cognitive Dysfunction
Cognition
National Heart, Lung, and Blood Institute (U.S.)
Independent Living
Twin Studies
Atrophy
Education
White Matter

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Swan, G. E., DeCarli, C., Miller, B. L., Reed, T., Wolf, P. A., Jack, L. M., & Carmelli, D. (1998). Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology, 51(4), 986-993.

Association of midlife blood pressure to late-life cognitive decline and brain morphology. / Swan, Gary E.; DeCarli, Charles; Miller, B. L.; Reed, T.; Wolf, P. A.; Jack, L. M.; Carmelli, D.

In: Neurology, Vol. 51, No. 4, 10.1998, p. 986-993.

Research output: Contribution to journalArticle

Swan, GE, DeCarli, C, Miller, BL, Reed, T, Wolf, PA, Jack, LM & Carmelli, D 1998, 'Association of midlife blood pressure to late-life cognitive decline and brain morphology', Neurology, vol. 51, no. 4, pp. 986-993.
Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 1998 Oct;51(4):986-993.
Swan, Gary E. ; DeCarli, Charles ; Miller, B. L. ; Reed, T. ; Wolf, P. A. ; Jack, L. M. ; Carmelli, D. / Association of midlife blood pressure to late-life cognitive decline and brain morphology. In: Neurology. 1998 ; Vol. 51, No. 4. pp. 986-993.
@article{f6fe3623782d422c893ddcbd1379df65,
title = "Association of midlife blood pressure to late-life cognitive decline and brain morphology",
abstract = "Objective: To investigate the association between midlife systolic blood pressure (SBP) and late-life cognitive decline and brain morphology in a sample of community-dwelling elderly men 68 to 79 years of age. Methods: Subjects are surviving members from the prospective National Heart, Lung, and Blood Institute Twin Study (intake, 1969 to 1972)who, when examined for a fourth time in 1995 through 1997, underwent brain MRI and repeated assessment of neurobehavioral functioning. Quantification of the MR images determined cerebral volume and total volume of white matter hyperintensities (WMHIs) for 392 subjects. Midlife SBP levels measured in 1970, 1980, and 1985 were used to classify subjects into low, medium, and high midlife SBP categories. A 10- year change in performance on the Mini-Mental State Examination, Digit Symbol Substitution Test, Benton Visual Retention Test, and Verbal Fluency Test was also calculated for these subjects. For all reported analyses, patients were treated as genetically unrelated individuals. Results: Subjects with high midlife SBP experienced a greater decline in cognitive performance and had larger WMHI volumes at follow-up in late life than did those with low midlife SBP. Decreased brain parenchyma and increased WMHI volumes were associated with decline in neurobehavioral functioning as measured in late life independent of age, education, and baseline levels of cognition. Conclusions: Midlife SBP is a significant predictor of both decline in cognitive function and MR volumetric measures of brain atrophy in late life. Because decline in neurobehavioral functioning was associated with decreased brain volume and increased WMHI volume, we conclude that the long-term impact of elevated SBP on decline in late-life neurobehavioral functioning is likely to be mediated through its chronic, negative effect on structural characteristics of the brain.",
author = "Swan, {Gary E.} and Charles DeCarli and Miller, {B. L.} and T. Reed and Wolf, {P. A.} and Jack, {L. M.} and D. Carmelli",
year = "1998",
month = "10",
language = "English (US)",
volume = "51",
pages = "986--993",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Association of midlife blood pressure to late-life cognitive decline and brain morphology

AU - Swan, Gary E.

AU - DeCarli, Charles

AU - Miller, B. L.

AU - Reed, T.

AU - Wolf, P. A.

AU - Jack, L. M.

AU - Carmelli, D.

PY - 1998/10

Y1 - 1998/10

N2 - Objective: To investigate the association between midlife systolic blood pressure (SBP) and late-life cognitive decline and brain morphology in a sample of community-dwelling elderly men 68 to 79 years of age. Methods: Subjects are surviving members from the prospective National Heart, Lung, and Blood Institute Twin Study (intake, 1969 to 1972)who, when examined for a fourth time in 1995 through 1997, underwent brain MRI and repeated assessment of neurobehavioral functioning. Quantification of the MR images determined cerebral volume and total volume of white matter hyperintensities (WMHIs) for 392 subjects. Midlife SBP levels measured in 1970, 1980, and 1985 were used to classify subjects into low, medium, and high midlife SBP categories. A 10- year change in performance on the Mini-Mental State Examination, Digit Symbol Substitution Test, Benton Visual Retention Test, and Verbal Fluency Test was also calculated for these subjects. For all reported analyses, patients were treated as genetically unrelated individuals. Results: Subjects with high midlife SBP experienced a greater decline in cognitive performance and had larger WMHI volumes at follow-up in late life than did those with low midlife SBP. Decreased brain parenchyma and increased WMHI volumes were associated with decline in neurobehavioral functioning as measured in late life independent of age, education, and baseline levels of cognition. Conclusions: Midlife SBP is a significant predictor of both decline in cognitive function and MR volumetric measures of brain atrophy in late life. Because decline in neurobehavioral functioning was associated with decreased brain volume and increased WMHI volume, we conclude that the long-term impact of elevated SBP on decline in late-life neurobehavioral functioning is likely to be mediated through its chronic, negative effect on structural characteristics of the brain.

AB - Objective: To investigate the association between midlife systolic blood pressure (SBP) and late-life cognitive decline and brain morphology in a sample of community-dwelling elderly men 68 to 79 years of age. Methods: Subjects are surviving members from the prospective National Heart, Lung, and Blood Institute Twin Study (intake, 1969 to 1972)who, when examined for a fourth time in 1995 through 1997, underwent brain MRI and repeated assessment of neurobehavioral functioning. Quantification of the MR images determined cerebral volume and total volume of white matter hyperintensities (WMHIs) for 392 subjects. Midlife SBP levels measured in 1970, 1980, and 1985 were used to classify subjects into low, medium, and high midlife SBP categories. A 10- year change in performance on the Mini-Mental State Examination, Digit Symbol Substitution Test, Benton Visual Retention Test, and Verbal Fluency Test was also calculated for these subjects. For all reported analyses, patients were treated as genetically unrelated individuals. Results: Subjects with high midlife SBP experienced a greater decline in cognitive performance and had larger WMHI volumes at follow-up in late life than did those with low midlife SBP. Decreased brain parenchyma and increased WMHI volumes were associated with decline in neurobehavioral functioning as measured in late life independent of age, education, and baseline levels of cognition. Conclusions: Midlife SBP is a significant predictor of both decline in cognitive function and MR volumetric measures of brain atrophy in late life. Because decline in neurobehavioral functioning was associated with decreased brain volume and increased WMHI volume, we conclude that the long-term impact of elevated SBP on decline in late-life neurobehavioral functioning is likely to be mediated through its chronic, negative effect on structural characteristics of the brain.

UR - http://www.scopus.com/inward/record.url?scp=0031685323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031685323&partnerID=8YFLogxK

M3 - Article

C2 - 9781518

AN - SCOPUS:0031685323

VL - 51

SP - 986

EP - 993

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -